Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5218523
Max Phase: Preclinical
Molecular Formula: C25H30FN3O
Molecular Weight: 407.53
Associated Items:
ID: ALA5218523
Max Phase: Preclinical
Molecular Formula: C25H30FN3O
Molecular Weight: 407.53
Associated Items:
Canonical SMILES: Cc1ccc(C(=O)N2CCC(CNCCCc3c[nH]c4ccc(F)cc34)CC2)cc1
Standard InChI: InChI=1S/C25H30FN3O/c1-18-4-6-20(7-5-18)25(30)29-13-10-19(11-14-29)16-27-12-2-3-21-17-28-24-9-8-22(26)15-23(21)24/h4-9,15,17,19,27-28H,2-3,10-14,16H2,1H3
Standard InChI Key: MPTXILTZFHIDGB-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 407.53 | Molecular Weight (Monoisotopic): 407.2373 | AlogP: 4.69 | #Rotatable Bonds: 7 |
Polar Surface Area: 48.13 | Molecular Species: BASE | HBA: 2 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 10.31 | CX LogP: 4.59 | CX LogD: 1.84 |
Aromatic Rings: 3 | Heavy Atoms: 30 | QED Weighted: 0.56 | Np Likeness Score: -1.13 |
1. Yuan RX, Jiang KY, Wu JW, Zhang ZX, Li MS, Li JQ, Ni F.. (2022) Synthesis and antidepressant activity of novel 1-(1-benzoylpiperidin-4-yl) methanamine derivatives selectively targeting SSRI/5-HT1A., 76 [PMID:36202190] [10.1016/j.bmcl.2022.129006] |
Source(1):